Gene · 3670
Papers3,753
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 3,753
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chemically modified mRNA beyond COVID-19: Potential preventive and therapeutic applications for targeting chronic diseases. | Biomed Pharmacother | 2022 | 34915673 | PubTator, text mining | PubMed |
| Where all the Roads Meet? A Crossover Perspective on Host Factors Regulating SARS-CoV-2 infection. | J Mol Biol | 2022 | 34914966 | PubTator, text mining | PubMed |
| Sequencing of a Chinese tetralogy of Fallot cohort reveals clustering mutations in myogenic heart progenitors. | JCI Insight | 2022 | 34905512 | PubTator, text mining | PubMed |
| Chemical approach to generating long-term self-renewing pMN progenitors from human embryonic stem cells. | J Mol Cell Biol | 2022 | 34893854 | PubTator, text mining | PubMed |
| Concomitant genetic defects potentiate the adverse impact of prenatal alcohol exposure on cardiac outflow tract maturation. | Birth Defects Res | 2022 | 34859965 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals that BMPR2 mutation regulates right ventricular function via ID genes. | Eur Respir J | 2022 | 34857612 | PubTator, text mining | PubMed |
| Human blastoids model blastocyst development and implantation. | Nature | 2022 | 34856602 | PubTator, text mining | PubMed |
| Moving Towards Induced Pluripotent Stem Cell-based Therapies with Artificial Intelligence and Machine Learning. | Stem Cell Rev Rep | 2022 | 34843066 | PubTator, text mining | PubMed |
| Establishment of Trophoblast-Like Tissue Model from Human Pluripotent Stem Cells in Three-Dimensional Culture System. | Adv Sci (Weinh) | 2022 | 34813178 | PubTator, text mining | PubMed |
| Group I PAKs in myelin formation and repair of the central nervous system: what, when, and how. | Biol Rev Camb Philos Soc | 2022 | 34811887 | PubTator, text mining | PubMed |
| EP300 Selectively Controls the Enhancer Landscape of MYCN-Amplified Neuroblastoma. | Cancer Discov | 2022 | 34772733 | PubTator, text mining | PubMed |
| Anti-C2 Antibody ARGX-117 Inhibits Complement in a Disease Model for Multifocal Motor Neuropathy. | Neurol Neuroimmunol Neuroinflamm | 2022 | 34759020 | PubTator, text mining | PubMed |
| Non-coding RNAs: key regulators of reprogramming, pluripotency, and cardiac cell specification with therapeutic perspective for heart regeneration. | Cardiovasc Res | 2022 | 34718448 | PubTator, text mining | PubMed |
| Human stem cell-derived thymic epithelial cells enhance human T-cell development in a xenogeneic thymus. | J Allergy Clin Immunol | 2022 | 34695489 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomics Reveals a Conserved Metaplasia Program in Pancreatic Injury. | Gastroenterology | 2022 | 34695382 | PubTator, text mining | PubMed |
| Neuroendocrine neoplasms of the pancreas: diagnosis and pitfalls. | Virchows Arch | 2022 | 34647171 | PubTator, text mining | PubMed |
| Threshold of heteroplasmic truncating MT-ATP6 mutation in reprogramming, Notch hyperactivation and motor neuron metabolism. | Hum Mol Genet | 2022 | 34635923 | PubTator, text mining | PubMed |
| Multiomics reveal unique signatures of human epiploic adipose tissue related to systemic insulin resistance. | Gut | 2022 | 34598978 | PubTator, text mining | PubMed |
| Generation and Analysis of Mosaic Spinal Cord Organoids Derived from Mouse Embryonic Stem Cells. | Methods Mol Biol | 2022 | 34562238 | PubTator, text mining | PubMed |
| An analysis of 130 neuroendocrine tumors G3 regarding prevalence, origin, metastasis, and diagnostic features. | Virchows Arch | 2022 | 34499237 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3670/papers?page=46